Zyversa Therapeutics Inc (ZVSA)

Currency in USD
0.1386
-0.0084(-5.71%)
Closed·
ZVSA Scorecard
Full Analysis
RSI suggests the stock is in oversold territory
ZVSA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.11100.1500
52 wk Range
0.11003.3700
Key Statistics
Prev. Close
0.147
Open
0.147
Day's Range
0.111-0.15
52 wk Range
0.11-3.37
Volume
40.94K
Average Volume (3m)
4.34M
1-Year Change
-95.41%
Book Value / Share
1.28
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ZVSA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Zyversa Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Zyversa Therapeutics Inc Company Profile

ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company that develops and commercializes products for the treatment of renal and inflammatory diseases. The company develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical trial for the treatment of renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100, a humanized monoclonal antibody that is in preclinical stage for treatment of inflammatory diseases comprising acute respiratory syndrome, multiple sclerosis, pancreatic cancer, Parkinson’s and Huntington’s disease, atherosclerosis, Alzheimer’s disease, and obesity. The company has a license agreement with L&F Research LLC, and InflamaCORE, LLC. ZyVersa Therapeutics, Inc. was founded in 2014 and is based in Weston, Florida.

Compare ZVSA to Peers and Sector

Metrics to compare
ZVSA
Peers
Sector
Relationship
P/E Ratio
−0.1x−3.1x−0.6x
PEG Ratio
0.000.010.00
Price/Book
0.2x2.1x2.6x
Price / LTM Sales
-8.9x3.3x
Upside (Analyst Target)
-176.6%37.9%
Fair Value Upside
Unlock−5.1%3.7%Unlock

Earnings

Latest Release
Aug 13, 2025
EPS / Forecast
-0.46 / -0.40
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ZVSA Income Statement

People Also Watch

4.8200
BTCS
+11.83%
5.67
REPL
+1.25%
53.49
BMNR
+12.07%
14.9000
INKT
-0.33%

FAQ

What Stock Exchange Does Zyversa Therapeutics Trade On?

Zyversa Therapeutics is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Zyversa Therapeutics?

The stock symbol for Zyversa Therapeutics is "ZVSA."

What Is the Zyversa Therapeutics Market Cap?

As of today, Zyversa Therapeutics market cap is 1.25M.

What Is Zyversa Therapeutics's Earnings Per Share (TTM)?

The Zyversa Therapeutics EPS (TTM) is -3.04.

From a Technical Analysis Perspective, Is ZVSA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Zyversa Therapeutics Stock Split?

Zyversa Therapeutics has split 2 times.

How Many Employees Does Zyversa Therapeutics Have?

Zyversa Therapeutics has 7 employees.

What is the current trading status of Zyversa Therapeutics (ZVSA)?

As of 23 Aug 2025, Zyversa Therapeutics (ZVSA) is trading at a price of 0.14, with a previous close of 0.15. The stock has fluctuated within a day range of 0.11 to 0.15, while its 52-week range spans from 0.11 to 3.37.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.